Atrophic Vaginitis
28
3
3
19
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
3.6%
1 terminated out of 28 trials
95.0%
+8.5% vs benchmark
32%
9 trials in Phase 3/4
42%
8 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (28)
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients
Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors
Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause
Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis
An Innovative Silicone Wound Dressing for the Management of Atrophic Vaginitis
a Flexible Wound Dressing for the Management of Genital Skin Conditions
A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis
A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis
Evaluation of Gynecological Acceptability of a Health Care Product
Vaginal and Urinary Microbiome Trial
Evaluation of Gynecological Acceptability of 3 Health Care Products
Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy